NCT06414304View on ClinicalTrials.gov

Dynamics of MSI and Genomic Profile of Colorectal Cancer In the Course of Immune Checkpoint Inhibitor Therapy

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

June 1, 2022

Primary Completion Date

September 1, 2024

Study Completion Date

March 1, 2025

Conditions
Colorectal CancerColorectal Cancer MetastaticMSI-H Colorectal CancerdMMR Colorectal CancerCancerColon Adenocarcinoma
Trial Locations (2)

115478

N.N.Blokhin National Medical Research Center of Oncology, Moscow

142770

"State Budgetary Institution of Healthcare of the City of Moscow Moscow Multidisciplinary Clinical Center Kommunarka of the Department of Health of the City of Moscow", Moscow

All Listed Sponsors
collaborator

N.N. Blokhin National Medical Research Center of Oncology

OTHER

collaborator

Moscow MultidisciplinaryClinical Center Kommunarka

UNKNOWN

lead

OncoAtlas LLC

INDUSTRY